Do telomerase antagonists represent a novel anti-cancer strategy?
1996
Do telomerase antagonists represent a novel anti-cancer strategy?
Editorial
Author Information
Author(s): EK Parkinson
Primary Institution: CRC Beatson Laboratories, Beatson Institute for Cancer Research
Hypothesis
Do telomerase antagonists represent a novel anti-cancer strategy?
Conclusion
Telomerase antagonists may provide a targeted approach to cancer therapy by specifically affecting tumor cells that rely on telomerase for survival.
Supporting Evidence
- 85% of human cancers reactivate telomerase to become immortal.
- Telomerase is detectable in over 80% of human tumor samples.
- Inhibition of telomerase limits the lifespan of immortal human tumor cells.
Takeaway
This article discusses how cancer cells use a special enzyme called telomerase to keep growing, and suggests that blocking this enzyme could be a new way to treat cancer.
Limitations
The article discusses potential resistance mechanisms to telomerase antagonists and the complexity of telomere biology.
Want to read the original?
Access the complete publication on the publisher's website